ID   CaOV3 CBPR
AC   CVCL_E3AS
RX   PubMed=35681748;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (from parent cell line).
CC   Omics: Metabolome analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0201 ! Caov-3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=35681748; DOI=10.3390/cancers14112763; PMCID=PMC9179525;
RA   Acland M., Lokman N.A., Young C., Anderson D., Condina M.R., Desire C.,
RA   Noye T.M., Wang W.-Q., Ricciardelli C., Creek D.J., Oehler M.K.,
RA   Hoffmann P., Klingler-Hoffmann M.;
RT   "Chemoresistant cancer cell lines are characterized by migratory,
RT   amino acid metabolism, protein catabolism and IFN1 signalling
RT   perturbations.";
RL   Cancers (Basel) 14:2763.1-2763.24(2022).
//